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ABSTRACT 
Objective: To evaluate the immunomodulatory activities of some of the common lichen compounds by using chemiluminescence based cellular 
assays. 
Methods: Number of secondary lichen metabolites, representing a breadth of lichen substances, was investigated for their effects on the respiratory 
burst of human whole blood phagocytes, isolated human polymorphonuclear leukocytes (PMNs) and murine macrophages using luminol or 
lucigenin-based chemiluminescence probes.  
Results: This study identify a clear suppressive effect of some lichen metabolites on phagocytosis response upon activation with serum opsonized 
zymosan by several lichen substances. Amongst the compounds tested, orsellinic acid, methyl orsellinate, methyl haematomate, lecanoric acid and 
lobaric acid, showed a potent immunomodulatory activity as compared to the standards. The lobaric acid suppressed both the myloperoxidase 
dependent and myloperoxidase independent, Reactive Oxygen Species (ROS) production in the oxidative burst of polymorphonuclear neutrophils 
(PMN) at the lowest concentration tested (3.1 µg/ml). Whereas, lecanoric acid, suppressed only the myloperoxidase dependent ROS production 
with IC50< 3.1µg/ml when compared to the standard sodium diethyldithiocarbamate trihydrate (SDT) (IC50 = 1.3 ± 0.2 µg/ml). Orsellinic acid, 
methyl orsellinate and methyl haematomate showed a selective myloperoxidase independent pathway with IC50 values; < 3.1µg/ml; 6.1 ± 1.0 
µg/ml;  3.3 ± 0.1 µg/ml, respectively, being lower as compared to standard SDT (IC50
Conclusion: Based on the results obtained it is appropriate to conclude that lichen are not only a good source of antioxidants, but also potent 
immunomodulators, and thus deserve to be investigated further. 
 = 8.2 ± 1.9 µg/ml).  
Keywords: Lichen compounds, Immunomodulatory activities, Lobaric acid, Lecanoric acid, Orsellinic acid, Methyl haematomate, Methyl orsellinate, 
lumino- or lucigenin based chemiluminescence assay. 
 
INDRODUCTION 
An immunomodulator is the substance that is capable of interacting 
with the immune system to up-regulate or down-regulate specific 
aspects of the host response [1]. It is also known as biologic 
response modifier or immune regulator. It can function as a drug 
leading predominantly to a non-specific stimulation of 
immunological defense mechanisms [2].  
Due to the broad applications, immunomodulators are becoming 
popular in the health industry for conditions such as in the 
treatment of transplantation rejection, recovery from infectious 
diseases, primary immunodeficiency’s, and to stabilize the immune 
system of HIV positive patients. Various disease conditions such as 
infections, cancer, rheumatoid arthritis, and systemic lupus erythro 
matosus are currently treated with novel immuno modulating 
agents [3]. Some of the most important sources of 
immunomodulators which are being currently explored include 
plants derived substances. Immunomodulation using plant- based 
natural products can also provide an alternative to conventional 
chemotherapy for a variety of diseases especially when the host 
defense mechanism needs to be activated under the condition of 
impaired immune response, or when a selective immune 
suppression is required in situations like autoimmune disorders.  
Several plants are known to have mitogenic effect on the immune 
cells. Examples include Acacia nilotica, Khayasenegalensis, Xanthium 
brasilicum, Tinospora bakis, Sutherlandia frutescens, Perilla 
frutescens, Lindolefia stylosa, Euphorbia kopetdagh, Climacoptera 
obtusifolia, Buxus hyrcana Pojark., Tinospora crispa, 
Andrographispaniculata, Labisiapumilavar. alata, Piper nigrum, 
Curcuma domestica, C. aeruginosa, Garcinia atroviridis, and G. 
mangostana, etc [4]. 
Whereas a variety of secondary metabolites such assaponins, 
flavanoids, monoterpenoids, diterpenes, triterpenoids, alkaloids, 
monoamines, withanolides, iridoid glycosides, organo sulphur 
compounds, etc. have been reported for immunomodulatory 
activities [5]. Few classes of natural products have received as much 
attention as phenolics and polyphenols as potential limmuno 
modulators of natural origin. It has been reported that phenolic 
compounds either stimulate or suppress the immune system due to 
the OH groups in their structure. This group helps in their 
interaction with enzymes which manifest as immunomodulating 
property, especially on phagocytic activity [6]. 
Lichens produce a wide variety of secondary metabolites, many of 
which are unique to lichenized state. In the tropics, lichens remain 
one of the least studied cryptogam, and from Sri Lanka, where the 
lichen substances used in this study were isolated, many new 
records and new species are being reported [7] and [8], making it 
Asia’s lichen hot spot. Interestingly orcinols, depsides, depsidones, 
and dibenzofurans, found in lichens, possess phenolic groups. 
During the past two decades, research on biological activities of 
lichens has seen an exponential increase [9]. Antioxidant activity has 
been the focus of the research. Numerous studies on antioxidant 
activities of lichen extract [10] and pure compounds have been 
reported [11-13]. However, reports on immunomodulatory 
activities of phenolic compounds, isolated from lichens, are rather 
scarce [14]. Reported antioxidant assays are based on free radicals, 
whereas the chemiluminescence studies reported herein are cell-
based assay. In this assay compounds, could interact with many 
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possible targets, intra- (with enzymes or with regulatory signaling 
molecules) or extra-cellular (receptor) along with the production of 
ROS. We report herein the immunomodulatory activities of some 
common lichen compounds, representative of the breadth of lichen 
substances, based on chemiluminescence assays.  
MATERIALS AND METHODS 
Lichen compounds 
We selected representative members of several classes of lichen 
metabolites (Figure 1). This includes the mononuclear aromatic 
compounds, namely orcinol (1), orsellinic acid (2), methyl 
orsellinate (3), methyl haematommate (4), methyl-β-
orcinolcarboxylate (5), montagnetol (6), p-depsides namely 
atranorin (7), lecanoric acid (8), erythrin (9), the m-depside sekikaic 
acid (10), the depsidone lobaric acid (11), the ubiquitous 
dibenzofuran (+) - usnic acid (12) and the triterpenoid, zeorin (13), 
isolated from the lichens Parmotrema grayana, Heterodermia 
obscurata, Rocella montagneii and Cladonia sp. [11]. 
Polymorphonuclear neutrophils (PMNs) Isolation  
Briefly fresh human blood was obtained by vein puncture aseptically 
from healthy volunteers (25–38 years of age) in hapranized tubes 
[15]. The buffy coat containing polymorphonuclear neutrophils 
(PMNs) was collected by dextran sedimentation, and the cells were 
isolated after the density gradient centrifugation. The (PMNs) were 
collected from the tube base along with the red blood cells 
(RBCs). Cells were obtained after the RBCs lysis by using 
hypotonic solution, and suspended in Hank's balance salt 
solution (pH 7.2), free of calcium and magnesium ions (HBSS--). 
At the time of the experiment, cells were adjusted to their 
required concentration by using HBSS++, containing calcium and 
magnesium [15]. 
Chemiluminescence assay for determination of immuno-
modulatory activity  
Luminol-enhanced chemiluminescence assay was performed as 
described by Helfand et al. (1982) [16]. The whole blood (diluted 
1:20) and PMNs (1 × 106), suspended in Hank’s balance salt solution 
containing calcium and magnesium (HBSS++), were incubated with 
25 µl of each test compounds 1–13, dissolved in MeOH at 
concentrations of 3.1–100 µg/ml for 15– 30 min. To the mixture was 
added 25 µl (20 mg/ml) of phagocytosis activator, zymosan 
(Saccharomyces cerevisiae origin; Sigma Chemical Co., St. Louis, MO), 
followed by chemiluminescence probe luminol (3-
aminophthalhydrazide) (G-9382 Sigma) 25 µl (7 × 105 mol). Then 
HBSS++ was added to adjust the final volume to 0.1 ml. HBSS++
Immuno-modulatory activity of test compounds was measured in 
the presence of two chemilluminescenses probes the luminol, 3-
aminophthalhydrazide and lucigenin, bis-N-methyllacridinium 
nitrate. Luminol probe can measure both intra- and extra-cellular 
ROS, especially O
alone 
without the compound was used as a control. The chemi 
luminescence’s peaks were recorded with a Lumino meter from 
Labsystems Luminoskan (Helsinki, Finland) for 50 min. in the repeated 
scan mode. Peak and total integral chemiluminescence reading was 
expressed in the relative light unit. If the test compound showed 
immunomodulatory activity, a reduction in chemiluminescence was 
observed. Similar reactions were repeated using another 
chemiluminescence probe, lucigenin (bis-N-methyllacridinium nitrate). 
RESULTS 
In order to test the immunomodulatory effect of the lichen 
compounds, we investigated their inhibitory effect in a range of 
concentrations (3.1 – 100 µg/ml) on the oxidative burst activity of 
whole blood phagocytes. Phagocytic cells upon activation induce 
release of reactive oxygen radicals in a process called oxidative burst 
which is then quantified using chemiluminescence assay. 
2―●, H2O2, and OH― free radicals, while lucigenin 
can detect extra-cellular ROS, especially O2―●, and OH― free radical. 
Consequently, both probes provide global ROS values, but no 
detailed information on intracellular levels of H2O2 or O2―●, etc. 
Ibuprofen and sodium diethyldithiocarbamate trihydrate (SDT) 
were used as the positive control. 
In the current study, our results showed the ubiquitous compounds 
which are present in almost all lichens namely the depside atranorin 
(7), dibenzofuran usnic acid (12) and triterpenoid zeorin (13) 
showed no significant immunomodulatory activity in any of the 
assays. Similarly, in our previous studies, we reported that these 
compounds possess no significant antioxidant activity, neither 
against DPPH (1, 1–Diphenyl–2–picrylhydrazyl radical) nor on super 
oxide inhibitory (SOI) or in nitric oxide (NO) radical scavenging 
assays. However, the m-depside sekikaic acid (10) and p-depside 
erythrin (9), which was reported to have high SOI activity, also did 
not show any immunomodulatory effect [11, 12]. 
On the other hand, the p–depside lecanoric acid (8) and the 
depsidone lobaric acid (11) which are reported to show high 
antioxidant activity in SOI assay, showed a moderate inhibitory 
activity in whole blood phagocyte assay with an IC50 of 23.2 ± 5.6 
µg/ml and 37.6 ± 0.9 µg/ml respectively, when compared to the 
standard Ibuprofen having an IC50 of 11.8 ± 1.9 µg/ml. From the 
compounds tested, lobaric acid showed most potent inhibitory 
activity in both intra- and extra-cellular reactive oxygen species 
(ROS) (IC50< 3.1 µg/ml) when compared to standards sodium 
diethyldithiocarbamate trihydrate (SDT)which showed IC50 1.3 ± 0.2 
µg/ml in intra-cellular luminol assay, and IC50= 8.2 ± 1.9 µg/ml in 
extra-cellular lucigenin assay. Whereas lecanoric acid (8) was more 
potent against intra-cellular ROS (IC50< 3.1 µg/ml), as compared to 
extra-cellular ROS (IC50 14.5 ± 2.6 µg/ml). 
Mononuclear aromatic compounds, methyl haematomate (4) and 
methyl orsellinate (3), showed a moderate effect on whole blood and 
intra-cellular ROS, however, they strongly inhibited extra-cellular 
ROS with IC50 values 3.3 ± 0.1 µg/ml and 6.1 ± 1.0 µg/ml, 
respectively, when compared to the standard SDT (IC50= 8.2 ± 1.9 
µg/ml). These compounds are reported to be in-vitro NO radical 
scavengers [11]. Similarly methyl-β-orcinolcarboxylate (5), which is 
also, reported as a potent NO scavenger, showed no effect on intra-
cellular ROS, but, showed a moderate inhibitory effect on extra-
cellular ROS from the whole blood (IC50 27.1 ± 8.4 µg/ml). On the 
other hand, orsellinic acid (2), which had shown moderate 
antioxidant activity in DPPH and SOI assay, showed a very potent 
immunomodulatory effect in all assays, including the highest on 
whole blood (IC50= 10.4 ± 0.5 µg/ml), which was higher than the 
standard Ibuprofen (IC50= 11.8 ± 1.9 µg/ml). The IC50 value of 
orsellinic acid (2) against intra-cellular ROS was 7.7 ± 1.7 µg/ml 
(standards SDT; IC50= 1.3 ± 0.2 µg/ml) and in extra-cellular ROS was 
< 3.1 µg/ml (standard SDT; IC50= 8.2 ± 1.9 µg/ml). The 
immunomodulatory activity of orcinol (1) and montagnetol (6) was 
insignificant. Results are tabulated in table-1. fig.1 illustrates the 
immunomodulatory activities of the compounds tested in whole 
blood phagocytes, over a wide range of concentrations, and with test 
standards Ibuprofen. 
DISCUSSION  
The chemiluminescence is an efficient and highly sensitive technique 
to investigate reactive oxygen species (OH, O-2 and H2O2, 
Increasing evidence suggests the importance of lichen compounds in 
the search of pharmaceuticals, especially with respect to Reactive 
Oxygen Species (ROS) scavenging activities. ROS have an important 
pathophysiological role in several types of autoimmune human 
diseases, and thus it is essential to treat oxidative stress, and thereby 
enhance the immunity of the body system. Thus the 
immunomodulatory agents are being used as adjuvant therapy in 
oxidative stress induced diseases. Similarly, antioxidants are 
compounds which react with free radical components, forming more 
stable complexes. Thus the searches for compounds with antioxidant 
and immunomodulatory effect have special therapeutic significance. 
With this aim, lichen compounds with reported antioxidant activities 
were evaluated for the irimmunomodulatory potential. 
NO), which 
are involved in a wide variety of clinical disorders, such as 
atherosclerosis, reperfusion injury, pulmonary toxicity, cancer and 
rheumatic arthritis. The compound able to modify or inhibit these ROS 
through cellular interactions is considered as an immunomodulator. A 
few clinical agents are available for the treatment of the oxidative 
stress. However, many of these drugs are associated with adverse side 
effects. On the contrary, the natural antioxidants can be safer choices 
for the treatment of oxidative stress. 
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 values of compounds1–13 at 5 different concentrations (6.2 – 100 µg/ml) in the oxidative burst of the whole blood, when 
compared to the Ibuprofen 
Table 1: Effects of compounds 1–13on the oxidative burst of whole blood and polymorphoneutrophils (PMN’s) activated with luminal and 
lucigenin as substrates 
Compounds IC50(µg/ml) 
 Whole blood  Polymophonucler neutrophils  
 Luminol Lucigenin 
Orcinol (1) 57.9 ± 11.0 37.5 ± 5.3 29.5 ± 8.8 
Orsellinic acid (2)  10.4 ± 0.5 7.7 ± 1.7 < 3.1 
Methyl orsellinate (3)  51.6 ± 3.6 23.6 ± 1.2 6.1 ± 1.0 
Methyl haematomate (4)  37.1 ± 7.3 15.2 ± 4.4 3.3 ± 0.1 
Methyl-β-orcinolcarboxylate (5) 71.4 ± 0.9 > 50 27.1 ± 8.4 
Montagnetol (6) 95.7 ± 5.3 20.6 ± 7.4 31.8 ± 4.6 
Atranorin (7)  > 100 9.8 ± 2.6 15.1 ± 5.6 
Lecanoric acid (8) 23.2 ± 5.6 < 3.1 14.5 ± 2.6 
Erythrin (9) > 100 - - 
Sekikaic acid (10) > 100 - - 
Lobaric acid (11)  37.6 ± 0.9 < 3.1 < 3.1 
Usnic acid (12)  > 100 - - 
Zeorin (13)  > 100 - - 
Ibuprofen 11.8 ± 1.9 2.5 ± 0.6 - 
Sodiumdiethyldithiocarbamatetrihydrate - 1.3 ± 0.2 8.2 ± 1.9 
Luminol, lucigenin assays were not carried out for compound which showed IC50
 
 values> 100 μg/ml in the whole blood assay. Values are expressed 
as mean ± SEM of 3 replicates (n = 3); P< 0.05 
Of the 13 compounds tested, compounds 2, 3, 4, 8 and 11 were found 
to posses in-vitro inhibitory activity against oxidative burst from 
whole blood upon activation with serum opsonized zymosan. 
Orsellinic acid (2) showed a potent inhibitory effect on the oxidative 
burst of the whole blood (IC50 10.4 ± 0.5 µg/ml), when compared to 
ibuprofen (IC50 11.8 ± 1.87 µg/ml). Lecanoric acid (8) and lobaric 
acid (11), on the other hand, showed a moderate inhibitory activity 
on the oxidative burst of whole blood with an IC50
However, lobaric acid suppressed both the myloperozidase dependent 
and myloperozidase independent ROS production in PMNs at the 
lowest concentration tested (3.1 µg/ml), whereas lecanoric acid was 
found to be significantly potent in the myloperozidase dependent 
pathway. On the other hand, orsellinic acid (IC
=23.2 ± 5.6 µg/ml 
and 37.6 ± 0.9 µg/ml, respectively.  
50< 3.1 µg/ml), methyl 
hematomate (IC50 3.3 ± 0.1 µg/ml) and methyl orsellinate (IC50 6.1 ± 
1.0 µg/ml) showed a selective myloperoxidase independent pathway 
as compared to the standard SDT (IC50
CONFLICT OF INTERESTS 
= 8.16 ± 1.9 µg/ml),which 
indicate its specificity against superoxide free radicals that is mainly 
released extra cellularly. All these compounds showed potent 
antioxidant activities, either in SOI or NO scavenging assay [11]. 
However, other compounds which showed in-vitro radical scavenging 
activities in antioxidant assays, such as sekikaic acid and erythrin [11] 
did not show any immunomodulatory effects. 
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